Microsoft Defender for IoT - OT Site License - Small Site - 250 max devices per site (12 Months Subscription)

Microsoft Defender for IoT - OT Site License - Small Site - 250 max devices per site (12 Months Subscription)

Marsoni

M251S

$1233.00

Get it in 3 business days with 1 day shipping. Friday, May 29

Microsoft Defender for IoT - OT Site License - Small Site - 250 max devices per site (12 Months Subscription)Accelerate digital transformation while improving security for OT environments. Microsoft Defender for IoT offers agentless network detection and response (NDR) that is rapidly deployed, works with diverse IoT, OT, and industrial control system (ICS) devices, and interoperates with Microsoft 365 Defender, Microsoft Sentinel, and external security operations center (SOC) tools.

Easy Shipping

Quick Dispatch:

Your Microsoft Defender for IoT - OT Site License - Small Site - 250 max devices per site (12 Months Subscription) orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Microsoft Defender for IoT - OT Site License - Small Site - 250 max devices per site (12 Months Subscription) ships.

Need Help?
Questions about Microsoft Defender for IoT - OT Site License - Small Site - 250 max devices per site (12 Months Subscription), sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Microsoft Defender for IoT - OT Site License - Small Site - 250 max devices per site (12 Months Subscription) in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

These work to keep my mouth moist for hours. The only downside is the glue stays in your mouth till you can scrape it out with your finger. I thought it would dissolve but it didn’t. Very grateful to find something that moistens my mouth for so long though. They’re easy to use too. Taste slightly sweet but otherwise I didn’t notice anything.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on October 8, 2024

Verified Purchase

Brad Smith

Chelsea, US

★★★★★ 5

Xylimelts Sensitive

I was sensitive to the regular Xylimelts after a few months use. Painful gums and hives inside my lips and cheeks. The sensitive version immediately corrected the problem and I’ve been using them without issue for nearly a year. The product is a lifesaver for drymouth that occurred when I was sleeping.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on March 28, 2026

Verified Purchase

Whislin ducks

Lexington, US

★★★★★ 5

Best that I have found for dry mouth.

These are the best for dry mouth at night. They mostly stay stuck. I say mostly because I have had a few come apart. I think that was my fault.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on February 20, 2026

Verified Purchase

Karen Strickholm

Omaha, US

★★★★★ 5

A Great Product!

These tablets are inspired! I use them every night with my cpap. The back of each tablet has a coating that, when moistened, is easily glued to a back tooth to slowly dissolve while sleeping. Works like a charm! These would be good to use when speaking publicly, too - no more performance dry mouth. You really can't tell it's there once it's glued in. The minty flavor is there, but not overwhelming. I am never without my Xylimelts!

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on July 18, 2025

Verified Purchase

Hillary S.

Bozeman, US

★★★★★ 5

Best price on a good product that works

Price and effectiveness of these lozenges if you suffer dry mouth at night makes it a very good buy on Amazon.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on January 28, 2026